Skip to main content
. 2014 Feb 24;5(9):2487–2498. doi: 10.18632/oncotarget.1740

Table 5. Link of DRscore with patients' genetic abnormalities Interphase-FISH-analysis was performed on CD138-purified plasma cells of 153 to 169 patients of the HM series, depending on the gene abnormality.

Patients were separated in two groups according to DRscore (low-risk and high-risk groups). Data are the percentages of patients within these 2 groups with the biological parameters. When the percentages were different with a chisquare test (P ≤.05), data are shown in bold.

DRscore ≤ −7.62 DRscore > −7.62
t(11;14)+(n = 27) 17% 15%
t(11;14)-(n = 140) 83% 85%
t(4;14)+(n = 28) 13% 28%
t(4;14)-(n = 137) 87% 72%
1q21+(n = 62) 33% 59%
1q21-(n = 91) 67% 41%
del13+(n = 91) 45% 77%
del13-(n = 78) 55% 23%
del17+(n = 27) 14% 24%
del17-(n = 132) 85% 76%